PKM and hepatocellular carcinoma: Clinical metabolomics studies have demonstrated elevated serum PKM2 levels in patients with hepatitis B virus (HBV)-related cirrhosis and HCC, suggesting its potential as a noninvasive biomarker for virus-associated liver cancer [46].